Company intelligence / Profile preview

First Vivos

Littleton, Colorado, United States

Ownership: Private
Development stage: Other

Overview

Vivos Therapeutics has developed The Vivos Method, a suite of FDA-cleared, noninvasive oral medical devices and clinical protocols for treating mild, moderate, and severe obstructive sleep apnea in adults and children. Clinical data demonstrate significant patient improvement in Apnea Hypopnea Index scores with average treatment duration around 12 months. Over 42,600 patients have been treated worldwide by more than 1,950 doctors.

Therapeutic areas: Pulmonology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Seneca Partners (strategic investment and distribution support)Sleep Center of Nevada acquisition (pending, expanding distribution)

Beyond the preview

Go deeper on First Vivos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Vivos.

Explore the full profile